Anti-neutrophil Cytoplasmic Antibodies (ANCA) in systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies

Journal of Association of Physicians of India

Volumn 52, Issue JUL, 2004, Pages 533-537

  Pradhan, Vandana D ^a   Badakere, S S ^a   Bichile, Lata S ^a   Almeida, A F ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED;

EID: 13744259698     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rose NR, Mackay IR. The autoimmune diseases Vol II., 1992; Academic press, INC, 279-300.
2. Joshi VR, Sainani GS. SLE the killer. J Assoc Physicians India 1987;36(7):473.
3. Van der Woude, Rassmussen FJN, Lobotto S, Wiik A, Permin HLA et al., Antibodies against neutrophils and monocytes : A new tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;I:425-9.
4. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E et al, Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney International 1998;53:743-53.
5. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Morkolongo R et al. Anti-neutrophil cytoplasmic antibodies in 566 European patients with Systemic Lupus Erythematosus : Prevalence, clinical associations and correlation with other autoantibodies. European concerted action on immunogenetics of SLE. Clin Exp Rheumatol 1998;16:541-6.
6. Zhao MH, Liu Z, Zhang YK, Wang HY. Anti-neutrophil cytoplasmic antibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 1998;13:2821-4.
7. Tan EM, Cohen AS, Frieo FJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-77.
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of SLEDAI : A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arth Rheum 1992;35:630-40.
9. Pradhan VD, Badakere SS, Iyer YS, Kumar R, Almeida AF. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders. J Postgrad Med 2003;49:5-10.
10. Rasmussen N, Sjolin C, Isaksson B, Bygren P, Wieslander J. An ELISA for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) J Immunol Methods 1990; 127 : 139-45.
11. Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase and antilactoferrin antibodies in patients with collagen diseases. J Clin Immunol 2000;20:279-86.
12. Halbwachs- Macarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against Cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79-84.
13. Ali US, Dalvi RB, Merchant RH, Mehta KP, Chablani AT, Badakere SS., Bhatia HM. Systemic lupus erythematosus in Indian children. Ind Ped 1989;26:868-73.
14. Hatfield M, Evans M, Suenaga R, Hassanein KM, Abdou NI. Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids. Clin Exp Immunol 1987;70:26-34.
15. Khanna UB, Bhivandkar MG, Almeida AF, Mittal BV, Chablani AT, Badakere SS., Bhatia HM., Acharya VN. Spectrum of renal involvement in SLE. J Assoc Physicians India 1987;35:623-26.
16. Pradhan VD, Badakere SS, Bichile LS, Dolas MP. Antibody to Ro/SS-A and La/SS-B in Systemic Lupus Erythematosus and other autoimmune disorders. J Assoc Physicians India 2002;50:762-65.
17. Molnar K, Kovacs L, Kiss M, Husz S, Dobozy A, Pokoerny G. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Clin Exp Dermatol 2002;27:56-61.
18. Edgar JDM, Mc Millan SA, Bruce IN, Conlan SK. An audit of ANCA in routine clinical practice. Postgrad Med J 1995;71:605-12.
19. Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG et al, Clinical implications of anti-neutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 2000;20:57-63.
20. Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 1997;16:70-5.
21. Manolova I, Danchiva M, Halacheva K. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus : Prevalence, antigen specificity and clinical associations. Rheumatol Int 2001;20:197-204.
22. Hauer HA, Bajema IM, van Hauwelingen HC, Ferrario F, Noel L. Et al , Renal histology in ANCA associated vasculitis. Differences between diagnostic and serologic subgroups. Kidney Int 2002;61:80-9.
23. Badakere SS, Pradhan VD, Almeida AF, Pawar AR. Use of immunofluorescence and Confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificites to myeloperoxidase and proteinase3. J Fluorescence 2004;14:459-63.
24. Savige JA, Chang L, Wilson D, Buchanan RR. Autoantibodies and target antigens in anti-neutrophil cytoplasmic antibody (ANCA)- associated vasculitides. Rheumatol Int 1996;16:09-14.
25. Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH et al. Anti-Lactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 1992;31:669-73.